Novigenix SA

Novigenix SA

Biotechnology Lausanne, Vaud, Ch 25 employees
Employees
25
Contacts
3
Emails
3

Novigenix SA Overview

Headquarters
Lausanne, Vaud, Ch
Website
novigenix.com
Industry
Biotechnology
Employees
25
Founded
2014
Funding
1.9M
Company Email
Available in AeroLeads

About Novigenix SA

Novigenix is a precision medicine Tech Bio offering state-of-the-art ImmunoTranscriptomic liquid biopsy solutions with unprecedented predictive capabilities for precision development of novel therapeutics. Our AI-enabled ISO-13485 certified RNA analytic platform delivers ImmunoPD biomarkers, insights into mechanism of action and resistance, and early markers for severe toxicity to accelerate clinical development. These scalable solutions are currently adopted in a number of FDA clinical trials providing actionable insights across therapeutic modalities including ADCs, radioligand therapy, cellular therapies, therapeutic vaccines, and immunotherapies. The LITOSeek™ Liquid ImmunoTranscriptOmic platform has been optimized for mapping the response of patient immune system to onset of disease and therapeutic intervention. Proprietary analytical pipelines integrate patient multi-omics data with advanced Machine Learning and artificial intelligence approaches for early detection of disease, development of novel therapeutics, and drug target discovery.

Novigenix SA Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

Novigenix SA Org Chart

Sample employees and titles
Name Title Contact
Christian Jauch Finance Executive / Biotech CFO
Email
Miro Venturi C-level Healthcare Industry Executive
Email
Dr. Jan Groen Chairman of the Board at Angle
View
Antoine De Weck Group Leader at the Children's Cancer
Email

Employees by Management Level

Individual contributor 10 profiles
Executive 4 profiles
Senior / Lead 3 profiles

Department Contact Coverage

Department Contacts Email Phone
IT 4 4 0
General 3 3 1
Executive 1 1 0

Novigenix SA Tech Stack

Data / AI 7 profiles

Compare Similar Companies to Novigenix SA